Author: Joseph Gerard

Closing the Referral Loop: How Care Coordination Prevents Patients From Falling Through the Gaps

Posted on by Joseph Gerard

Nursing writing on a clipboard

Written by Zain Qayyum,

Continuity of care is usually taught as a clinical idea. The same clinician, or at least the same care team, follows a patient over time so that nothing is forgotten and no decision is made without context.

In day-to-day practice, continuity tends to fail for nonclinical reasons. It fails because a document did not move, a phone call was not made, or a decision sat in a queue that nobody owned. The clinical judgment was sound. The administrative follow-through was not.

Nowhere is this clearer than at the referral. A referral is the moment a patient passes from one organization to another, and it is the point where continuity is most exposed. For case managers, care coordinators, nurse navigators and anyone responsible for a patient across settings, understanding exactly where that hand-off breaks is the difference between a referral that becomes an appointment and one that quietly disappears.

Where Continuity of Care Actually Breaks

A referral looks like a transfer. It behaves like a hand-off.

In a transfer, responsibility moves cleanly from one party to another, and the receiving party confirms they have it. In a hand-off between separate organizations, with separate systems, separate staff, and separate priorities, there is a window where nobody is certain who holds the patient. That window is where continuity is lost.

The scale of this is well documented. A retrospective cohort study of 38,334 specialty referrals to a children’s hospital, published in The Journal of Pediatrics in 2023, found that 62% of referrals resulted in an appointment being scheduled and 54% resulted in a completed visit. Nearly half of referred patients never arrived. The study also found completion was lower for Black patients, Native Hawaiian and Pacific Islander patients, Spanish-speaking families and publicly insured patients, which tells us these gaps do not fall evenly.

The communication failure runs in both directions. The landmark Milbank Quarterly review of specialty referrals in the United States described breakdowns at every stage of the referral process, and noted that primary care physicians frequently do not know whether a patient actually attended the specialist, or what the specialist recommended. A referral can be clinically appropriate, accepted, attended, and still fail as an episode of coordinated care, simply because the information never returned to the person who initiated it.

The Six Stages a Referral Passes Through

Most discussion of referral management treats it as a single event. It is more useful to treat it as a sequence, because the failures cluster in specific places.

A referral typically moves through six stages:

  1. The referral arrives, usually as a document.
  2. Someone identifies what it is and extracts the patient and referring provider.
  3. Someone checks insurance and any authorization requirements.
  4. Someone decides which provider and which appointment type it needs.
  5. Someone contacts the patient and books, or records that booking is not possible.
  6. A report goes back to the referring clinician.

Stages That Fail Loudly

Stages one through three fail in visible ways. A document arrives in the wrong place. A name is misread. An authorization requirement is missed, and the claim is denied later.

These failures are frustrating, but they are recoverable, because something or someone eventually notices. A denied claim generates a task. A misfiled document gets found when somebody goes looking for it. The system produces a signal.

Stages That Fail Silently

Stages four and five are different. These are the stages that require a judgment: which provider is right for this patient, what appointment type this warrants, what to do when the patient cannot be reached or cannot be accommodated.

When a judgment has no clearly assigned owner, the referral simply waits. It has been received correctly. It has been read correctly. Nothing about it is wrong. It is sitting in a queue, complete and accurate, waiting for a decision that nobody has been made responsible for making.

Why Silent Failures Are the Hardest to Catch

This is the central problem in referral coordination, and it is worth stating plainly: a referral waiting on a judgment produces no error state.

Every quality process we build is designed to catch wrong things. Exception reports, denial queues, incomplete-record flags. A referral stuck at the provider-matching stage triggers none of them, because by every available measure it is in good order.

The practical test for whether this is happening in your organization takes about a minute. Ask how many referrals arrived last month, and you will get a precise number. Ask how many of those patients were never contacted, and in most organizations you will get an estimate or a pause. The first question counts documents, which systems do well. The second requires knowing what should have happened next, which is a coordination question, not a record-keeping one.

If the second number is not readily available, referrals are almost certainly being lost, and nobody will be able to say how many.

What Care Coordinators Can Measure

Three measures surface silent failure better than referral volume does.

Time From Arrival to First Patient Contact

Not time to filing, and not time to processing. Time from the referral arriving to the moment someone actually speaks to or reaches the patient.

Time to filing is the measure most organizations can produce easily, and it is the one that flatters them. A referral can be filed within an hour and sit unactioned for three weeks. Time to first contact is what the patient experiences, and it is the only one of the two that correlates with whether they eventually attend.

Referrals Received Against Referrals Contacted

A simple ratio, calculated monthly, from two numbers that most organizations hold separately and rarely compare. The gap between them is your leakage, and seeing it as a single figure tends to change the conversation faster than any amount of process mapping.

Look at referrals from two months ago rather than last month, so that anything genuinely still in progress has resolved.

Unbookable Referrals, Counted With Reasons

Some referrals cannot be booked. The patient declines, moves away, is not appropriate for the service, or cannot be reached after reasonable attempts. That is legitimate.

What is not legitimate is for those referrals to leave no record. If a patient cannot be booked, that should be an explicit status with a reason attached, and it should generate a message back to the referring office. Counting these monthly tells you something useful about demand, access and referral quality. Leaving them uncounted means a genuine inability to serve a patient is indistinguishable from an administrative failure to try.

Closing the Loop Back to the Referring Clinician

An appointment attended is not a closed loop. The loop closes when information returns to the clinician who initiated the referral.

This is formalized in CMS Quality ID #374, “Closing the Referral Loop: Receipt of Specialist Report,” which sits in the Effective Communication and Care Coordination domain. The measure holds the referring clinician accountable and asks a single question: did the referring clinician receive a report back from the clinician they referred to?

It is worth noticing what that measure does not ask. It does not ask whether the referral was sent, whether it was received, or whether the patient attended. It asks whether information came back. That reflects something coordinators understand instinctively: a referral where the patient was seen but the referring clinician learned nothing has produced a visit without producing continuity.

For referring offices, the practical consequence is that the single most valuable thing a specialist can send is not the consult note weeks later. It is a short acknowledgment on the day of receipt, confirming the referral arrived and will be actioned, followed by confirmation of what was booked or why it could not be. Those two messages cost almost nothing and resolve the uncertainty that otherwise drives repeat calls, duplicate referrals and patients falling between two organizations each assuming the other holds them.

Both are also the easiest part of the loop to automate, since neither message needs a person to compose it. Sending them reliably is standard in referral workflow tools such as Medsender.

Practical Steps for Care Coordination Teams

Separate the Decision Queue From the Processing Queue

Referrals awaiting a judgment behave completely differently from referrals awaiting processing, and mixing them in one list hides the first behind the second.

Maintain them separately, and make sure the decision list sits in front of the person authorized to make that decision. The volume is usually small. The delay is usually large. It is one of the few changes in this area that costs nothing and shows a difference within a month.

Make the Unbookable Message Standard

Agree on a short, standard message that goes back to the referring office whenever a patient cannot be booked, with the reason. Most organizations have no such message, and the default is silence.

Silence is read by the referring office as the referral having been received and handled. It is the single most common reason a patient is lost while two organizations each believe the other is responsible.

Agree Who Owns the Patient Between Organizations

The window between referral sent and appointment booked is where ownership is genuinely ambiguous. Most referral agreements specify clinical criteria and say nothing about this window.

Write it down. State how long the receiving organization has to make contact, what happens after a set number of failed contact attempts, and at what point responsibility returns to the referring clinician. This is not a technology question, and organizations that answer it clearly lose fewer patients than those with better systems and no agreement.

Conclusion: Continuity Is an Administrative Discipline

Continuity of care is often described as a quality of the clinical relationship. The evidence suggests it is at least as much a property of the administrative process surrounding that relationship.

Nearly half of referred patients in a large cohort study never completed the visit. Referring clinicians routinely do not find out what happened to the patients they sent. Neither of these is a failure of clinical judgment, and neither will be solved by clinical training.

For case managers, care coordinators and anyone holding responsibility for a patient across settings, the useful work is unglamorous and specific. Find the stages where a decision has no owner. Measure contact rather than filing. Say something back when a patient cannot be booked. Agree in writing who holds the patient in the gap.

The referrals that get lost are rarely the complicated ones. They are the ordinary ones, correctly received and accurately recorded, waiting for a decision nobody was asked to make.

Author Bio: Zain Qayyum is co-founder and co-CEO of Medsender, a healthcare workflow automation company. He was studying pre-med and interning in a hospital emergency department when he first saw how much of patient care depends on paperwork moving correctly, and he left pre-med for computer science to work on the problem. He led development of Medsender’s first AI models and the prototype of its voice agent, and writes about referral workflow, document intake and front office operations in specialty practices.

References 

Centers for Medicare & Medicaid Services. (n.d.). Quality ID #374: Closing the referral loop: Receipt of specialist report. Quality Payment Program. https://qpp.cms.gov

McDonald, K. M., Schultz, E., Albin, L., Pineda, N., Lonhart, J., Sundaram, V., Smith-Spangler, C., Brustrom, J., Malcolm, E., Rohn, L., & Davies, S. (2014). Care coordination measures atlas update (AHRQ Publication No. 14-0037-EF). Agency for Healthcare Research and Quality. https://www.ahrq.gov/ncepcr/care/coordination/atlas.html

Mehrotra, A., Forrest, C. B., & Lin, C. Y. (2011). Dropping the baton: Specialty referrals in the United States. The Milbank Quarterly, 89(1), 39–68. https://doi.org/10.1111/j.1468-0009.2011.00619.x

Srinivasan, A. P., Sullivan, E., Desai, A., Adiele, A., Bell, S., & Lion, K. C. (2023). Disparities in pediatric specialty referral scheduling and completion. The Journal of Pediatrics, 260, 113485. https://doi.org/10.1016/j.jpeds.2023.113485

How Pathology Labs Choose an LIS Provider

Posted on by Joseph Gerard

Computer laptop with medical sign icon concept of telemedicine a

Written by Sonia Munir,

Ask a lab director why they started looking for a new LIS, and there’s usually a story behind it. Maybe the vendor said it would stop supporting the product. Maybe a merger left the group with three practices on three separate systems. Molecular testing has pushed some labs into a search, while others just have pathologists who are sick of signing out cases in one window and looking at slides in another.

Nobody’s in a hurry once the search starts, because the winner may stick around for ten years or so. Labs go about it differently, though a few steps show up almost every time.

Start With the Committee

IT can tell you plenty about security and interfaces, but it may not notice that a system makes block tracking harder for histology. A business office focused on price can miss just as much, which is why labs tend to pull people from several departments early on.

You’ll usually see a director or operations lead on the committee and a pathologist who signs out a lot of cases. Add the histology supervisor, someone from billing, and someone from IT. They won’t agree on everything. A pathologist trying to get through a worklist has very different concerns than a biller who’s checking whether charges will drop correctly, and it’s better to hash those out during the evaluation than after go-live, when changes get expensive.

Follow a Case Through the Lab

Pick a recent case and walk it through accessioning, grossing, histology, sign-out, and billing. Plenty of labs do this before a vendor ever hears from them. It can be tedious. Still, it’s one of the easiest ways to find out where staff are typing the same information twice or keeping a spreadsheet because the current system falls short.

Those notes turn into a requirements list. Specialty support will probably be near the top, along with interfaces for the EHRs that referring physicians use. Once the list is in writing, it’s easier to stay grounded when a vendor shows off an impressive feature that nobody in the lab would use.

Think about the next few years while you’re at it. Will the group open more sites? Grow its outreach business? Start scanning slides? Any of those plans could change which system makes sense.

Build a Shortlist

Few labs have time to look at every LIS on the market, and specialty focus rules out a lot of them anyway. Plenty of systems started out in clinical labs that run large volumes of chemistry and hematology tests. They’re comfortable with numeric results but less so with anatomic pathology, where one case can involve several specimens, recuts, and special stains before the pathologist ever writes a narrative diagnosis. Pathology groups generally want software designed with those cases in mind.

Hosting usually comes up around the same time. More labs have moved to the cloud because they’d rather not maintain servers, and remote sign-out gets easier too. Some hospital-based labs just stay with the lab module in their enterprise EHR.

Then people start making calls. Lab directors know each other from conferences and professional groups, and many will ask a peer what they’re using and whether they like it. A good report from someone running a similar lab can get a vendor on the list pretty quickly.

Ask for Real Scenarios in the Demo

Product tours only show what the vendor wants you to see. Buyers who’ve been through this before show up with their own cases and make each vendor work through them from start to finish, using the same ones for everybody. A surgical case with multiple parts and add-on stains is a good test. So is an amended report or a rush specimen, and you’ll want at least one case where the charge has to go out with the right codes.

Seeing the same work in each system makes comparisons a lot easier. Count the clicks. Watch what happens with add-on stains and whether anyone has to resort to a workaround. If you can, get pathologists into the session and let them try the reporting tools, since they’ll be using them all day. It’s hard to win them over later if they don’t like signing out cases in the system.

Bring Up Digital Pathology

Labs with no plans to buy a scanner are asking about this now too. The LIS they choose could easily still be in place when they go digital, so they want to know what that move would involve.

One big question is where the slide images will be stored. Some setups keep them in a separate image management system and use an interface to match them with cases. Others keep the images and the case together in one LIS record. Labs have found that the separate route can add handoffs and make it harder to confirm that each slide is tied to the right patient. Many also ask if they can hold on to the scanners they own and add digital work in stages.

Call References and Read the Contract

Reference calls can settle a close race. Ask for customers around your lab’s size and in the same specialty, then find out how long implementation really took and what went wrong at go-live. How did support respond when something broke late on a Friday? Would they sign with the same vendor again?

The contract needs a careful read as well, because a low quote may not stay low. Check whether it covers implementation, interfaces, data migration, training, and support. You’ll also want to know how pricing changes as volume grows and what happens to your data if you ever leave.

Make the Call

It’s rare for one feature to decide the whole thing. Labs usually pick the provider that knows pathology and fits the way they work, as long as the system connects well with referring physicians and billing and the vendor has a realistic plan for what comes next.

A lot of independent pathology groups and reference labs end up looking at pathology-specific vendors for those reasons. NovoPath is one example, with a cloud-based LIS that has the digital pathology software built in. Every lab has its own priorities, of course, but a careful search now makes it less likely that it’ll be doing all this again in a few years.

Author’s Bio

Sonia Munir is a content writer at LinkTrixx, where she writes and edits articles for publishers and brands across a range of industries. She focuses on clear, well researched writing that is easy for readers to follow and trust.

 

Please also review AIHCP’s Clinical Research Health Care Specialist Certification and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

6 Healthcare Quality Analytics Platforms Every Health Care Quality Manager Should Know in 2026

Posted on by Joseph Gerard

MacBook Pro near white open book and coffeeWritten by Cass Rosas,

Quality managers carry an odd burden. They’re expected to prove improvement to regulators and payers, yet the data behind that proof usually sits in a dozen disconnected systems. Charts still get abstracted by hand, and a single patient encounter can count toward several programs at once.

The workload is larger than most people outside the quality department assume. When researchers at Johns Hopkins catalogued one hospital’s reporting obligations, they identified 162 unique quality metrics and estimated that preparing and reporting the data took 108,478 person-hours in a single year. Personnel costs came to more than $5 million, plus roughly $600,000 in vendor fees (Saraswathula et al., 2023).

Quality analytics platforms are meant to cut that workload and give teams time back for improvement work. Each of the six below solves a different problem, so read this list as a matching guide. The right choice depends on where your organization’s biggest gap sits: regulatory reporting, provider performance, patient experience, population health, or safety.

What Healthcare Quality Analytics Platforms Actually Do

A quality analytics platform pulls clinical, claims, survey, and event data into one place and calculates performance against defined measures. The platform ships with the measure specifications, including numerator and denominator logic, and updates them when CMS or NCQA revises a measure. With a general BI tool such as Tableau, someone on staff has to build and maintain that logic by hand. Many also submit results directly to CMS.

Quality management software in the narrower sense does a different job. Incident reporting and corrective and preventive action (CAPA) tools document what happened and how the organization responded. Analytics tools measure performance over time. Most quality departments need both, and a few vendors sell both.

These platforms touch nearly every recurring obligation a quality manager has. That list includes electronic clinical quality measures (eCQMs) for the Hospital Inpatient Quality Reporting (IQR) Program, MIPS for clinicians, HEDIS and Medicare Star Ratings for health plans and their provider partners, and HCAHPS for patient experience. Patient safety indicators feed directly into accreditation readiness for The Joint Commission.

How We Chose These 6 Platforms

We judged each platform on five criteria:

  • Data sources supported, including EHR, claims, patient surveys, and incident reports
  • Measure libraries, meaning prebuilt and maintained measure logic for CMS and NCQA programs
  • Regulatory submission support where it applies
  • Benchmarking against national or peer data
  • Usability for quality staff who aren’t trained data analysts

We also picked each one to cover a distinct use case. A hospital working through eCQM submission and a self-insured employer trying to steer members toward stronger physicians both need quality analytics. They need very different tools to get it.

6 Healthcare Quality Analytics Platforms to Know in 2026

1. Garner Health: Provider Quality and Outcomes Data

Garner Health measures performance for individual physicians.

Garner reports that it has compiled more than 60 billion medical records from 320 million patients and uses them to identify which doctors diagnose more accurately and achieve better patient outcomes (Garner Health, n.d.). The data is claims-based, so it shows what happened to patients in the months after a visit as well as whether a process step was documented.

That matters most in referral and network decisions. Two orthopedic surgeons in the same network can have very different complication and revision rates, and a standard facility dashboard won’t separate them. Outcome-based provider data gives quality and care management teams an objective basis for steering patients and for value-based care discussions with employers and health plans.

Garner’s primary customers are self-funded employers and the brokers who advise them, with employees as the end users. Hospital quality departments are more likely to run into it through payer and employer partnerships than as an internal reporting system, though Garner does license its provider data directly to health systems and carriers

2. Medisolv: eCQM and CMS Quality Reporting

Medisolv sticks to the regulatory side of quality. Its software calculates and validates eCQMs from EHR data and supports submissions for Hospital IQR and MIPS, among other CMS programs.

The practical appeal is early warning. Quality teams can watch measure performance through the year and fix documentation gaps months before a submission deadline. Medisolv fits hospitals and physician groups whose main pain point is CMS reporting. Organizations looking for a broad enterprise data platform will probably find it too narrow.

3. Health Catalyst: Enterprise Clinical Quality Improvement

Health Catalyst covers far more ground. It pairs a healthcare data platform with analytics applications and improvement services for health systems running many improvement projects at once.

Its strength is breadth. A health system can bring clinical and financial data together and track a sepsis bundle project alongside a readmissions effort in the same environment. That breadth comes with a real implementation commitment, including data engineering staff and executive sponsorship. Smaller hospitals often can’t justify it.

4. Press Ganey: Patient Experience and Safety Analytics

Patient experience has direct financial consequences, since HCAHPS results feed into CMS Hospital Value-Based Purchasing. Press Ganey is best known for patient experience surveys and for benchmarking results against a large national comparison database.

It’s most useful when quality managers read experience data next to clinical and safety data. A unit with falling nurse communication scores and rising medication events probably has one underlying problem. Press Ganey also measures workforce engagement and safety culture, which helps when staffing sits underneath a quality issue.

5. Arcadia: Population Health and HEDIS Gap Closure

Arcadia serves organizations accountable for a defined population, such as ACOs and physician groups in value-based contracts. Its platform combines claims and clinical data to surface care gaps (overdue screenings, uncontrolled chronic conditions) and to track HEDIS and Star Ratings performance.

The difference from Medisolv is the unit of measurement. Medisolv tells a hospital whether it met its measures. Arcadia tells a care team which patients in its panel still need something done. For quality staff in ambulatory or payer settings, that patient-level work list is often the most useful output.

6. RLDatix: Patient Safety and Incident Analytics

Safety data needs its own tool. Reviewing a random sample of 2,809 admissions across 11 Massachusetts hospitals, Bates et al. (2023) found at least one adverse event in 23.6% of admissions and judged 22.7% of those events preventable.

RLDatix, which includes the long-established Datix incident reporting system, captures safety events and near misses and trends them by unit and severity. Those trends support root cause analysis and give surveyors the documentation they expect. RLDatix works best alongside the other tools on this list, because incident data catches harm that outcome and process measures can miss.

How to Match a Platform to Your Quality Program

The table below summarizes where each platform fits.

Platform Primary quality use case Best-fit setting Main data source
Garner Health Provider-level outcomes and referral quality Employers, health plans, care management Claims
Medisolv eCQM and CMS program reporting Hospitals, physician groups EHR
Health Catalyst Enterprise improvement across service lines Large health systems EHR, financial, operational
Press Ganey Patient experience and safety culture Hospitals, health systems Patient and staff surveys
Arcadia Care gaps, HEDIS, value-based contracts ACOs, payers, ambulatory groups Claims and EHR
RLDatix Incident reporting and safety trending Hospitals, long-term care Incident and event reports

 

Start with the problem that eats the most staff time or carries the most financial risk. Before booking demos, check whether the tool connects cleanly with your EHR and whether its measure library covers the programs you actually report to. Then be honest about whether your team can maintain it after go-live.

Questions to Ask During a Vendor Demo

  • How do you validate measure logic each year when CMS or NCQA updates specifications?
  • How often does data refresh, and how long is the lag between a patient encounter and its appearance in a dashboard?
  • Where do benchmarks come from, and how large is the comparison group?
  • Can quality staff build or adjust reports without submitting a request to IT?
  • What analyst or clinical support does the contract include, and what costs extra?
  • Can we speak with a current customer of similar size and setting?

Building Data Skills on Your Quality Team

Software doesn’t interpret itself. Every platform on this list depends on staff who can read a measure specification and catch an exclusion applied incorrectly. They also need to tell a real performance change from a documentation artifact. Teams without those skills tend to produce attractive dashboards that nobody trusts.

So the investment has to cover people as well as technology. Quality professionals who understand measurement science and the regulatory programs behind the numbers get far more out of any platform they adopt. AIHCP’s Health Care Quality Management Certification is one route for nurses and allied health professionals who want formal training in those competencies.

Frequently Asked Questions

What Is a Healthcare Quality Analytics Platform?

A healthcare quality analytics platform is software that collects clinical, claims, survey, or event data and calculates performance on defined quality measures. Most include prebuilt measure logic and benchmarking against peer or national data, with dashboards that show where performance falls short. Some also submit results to CMS or other reporting bodies. The point is to move staff time from gathering data to improving care.

Is Quality Analytics the Same as Quality Management Software?

No. Quality analytics measures performance on outcome and process measures over time. Quality management software documents events and the organization’s response to them, through tools such as incident reporting and CAPA tracking. Many quality departments use both, and some vendors, including RLDatix, sell products in each category.

What Data Sources Do Quality Analytics Platforms Use?

Quality analytics platforms typically draw on EHR data, administrative claims, patient experience surveys, and incident reports. The source determines what the tool can measure. EHR data supports eCQMs and process measures, while claims data supports outcomes and utilization across care settings. Surveys add the patient’s perspective. Platforms that combine several sources give the fullest picture but take more integration work.

Do Small Practices Need a Dedicated Quality Analytics Tool?

Not always. Small practices with limited reporting obligations can often meet MIPS requirements through their EHR’s built-in reporting or a qualified registry. A dedicated platform starts to make sense once a practice joins value-based contracts or needs patient-level care gap lists to manage a defined population. Reporting volume and financial risk should drive the decision.

 

Author bio:

Cass Rosas is a content writer who covers healthcare technology, data, and analytics. She researches how health systems, payers, and employers use software to measure and improve care quality, and writes guides that help healthcare professionals compare tools.

 

Please also review AIHCP’s Health Care Quality Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Medicare Part B After 65: A Practical Guide for Healthcare Professionals and Their Families

Posted on by Joseph Gerard

Nurse Visiting Senior Male Patient At Home

Written by Danielle K Roberts,

Working past 65? Learn when you can delay Medicare Part B, how COBRA and HSAs affect timing, and how to avoid late enrollment penalties.

Turning 65 does not always mean that Medicare Part B should be started immediately. For healthcare professionals who continue working beyond 65, knowing when Part B is required and when it can be delayed is important. The Boomer Benefits’ Medicare Part B guide can help clarify whether someone needs Part B based on their current coverage, employment situation, and Medicare eligibility.

What Does Medicare Part B Actually Cover?

Medicare Part B is one of two parts of Original Medicare. While Part A generally covers inpatient hospital care, Part B helps pay for outpatient services, such as doctor visits, outpatient care, preventive care, durable medical equipment, and other medically necessary services.

Most people will pay a monthly premium for Medicare Part B, which is one reason some people who are still working may decide to go past their Initial Enrollment Period and enroll later. The choice depends largely on what other health coverage they have.

For healthcare professionals, this distinction can be particularly relevant. Physicians, nurses, therapists, administrators, and other healthcare workers may continue practicing well beyond 65 and remain covered by an employer health plan. Their Medicare decisions may look very different from someone who retires at 65 and has no other employer coverage.

How Working Past 65 Changes the Enrollment Decision

Someone who has health insurance through their own or their spouse’s current employment may be able to delay Part B without incurring a late enrollment penalty. However, the type of employer coverage and the size of the employer matters.

Check with the employer’s benefits administrator before deciding whether you can postpone enrollment without consequences. In some situations, job-based coverage may not pay properly if an eligible employee does not have Medicare Part A and Part B.

This is especially important for professionals who work for smaller practices, medical groups, or other organizations. Do not assume that having an employer health plan automatically means delaying Medicare.

The safest approach is to ask the benefits administrator how the employer plan coordinates with Medicare and whether the employee is expected to enroll in Original Medicare.

What Happens When Employer Coverage Ends?

If someone delayed Part B because they or their spouse continued working and had qualifying employer group health coverage, they typically qualify for an eight-month Special Enrollment Period after the employment or group health coverage ends, whichever comes first. This allows them to enroll in Part B without a late enrollment penalty.

However, waiting until the last minute can create unnecessary problems. Someone who wants Medicare to begin immediately after employer coverage ends may need to submit their enrollment paperwork before that coverage terminates.

Don’t Assume COBRA Extends Your Medicare Deadline

COBRA can create confusion because it allows someone to temporarily continue employer health insurance after leaving a job. But COBRA does not extend the eight-month Special Enrollment Period for Part B.

Medicare specifically advises people not to wait until COBRA coverage ends before enrolling in Part B. If someone is already eligible for Medicare, COBRA generally does not give them additional time to delay Medicare enrollment without consequences. COBRA is also not considered creditable for Part B, meaning they can refuse to pay since Medicare is supposed to be primary.

This is an easy detail for family members to overlook, particularly when they are focused on maintaining uninterrupted health coverage during a retirement transition.

Retiree Coverage Is Different From Current Employer Coverage

Another common source of confusion is retiree insurance.

Coverage offered by a former employer or union does not work the same way as active insurance from current employment. Often, retiree coverage may require someone to have both Medicare Part A and Part B before the retiree plan will pay its share of medical expenses.

If someone is approaching Medicare eligibility, they should ask the plan administrator exactly how the coverage coordinates with Medicare. Some people assume that retiree insurance will replace Medicare, so they choose not to enroll to avoid the Part B monthly premium. However, doing so can result in potential financial consequences and a gap in coverage.

Healthcare Professionals Should Watch Their HSA, Too

Healthcare professionals who remain employed and contribute to a Health Savings Account have another consideration when approaching Medicare.

Once someone enrolls in Medicare, HSA contribution rules can become an issue. People with an HSA need to coordinate the timing of their Medicare enrollment and HSA contributions carefully. Once enrolled in Medicare, you can no longer contribute to an HAS, or you risk an IRS penalty. So, timing matters. In particular, people approaching retirement at 65 or applying for Social Security should understand the potential consequences of being auto-enrolled in Part A.

If you are past 65, make sure you stop HSA contributions at least 6 months before enrolling in any part of Medicare. You can discuss the transition with a qualified tax professional and your benefits administrator before making decisions.

What If Someone Misses Their Initial Enrollment Period?

People who do not have qualifying employer coverage should not assume they can simply enroll in Part B whenever they please.

The Initial Enrollment Period generally surrounds the month someone turns 65. If they miss that window and do not qualify for a Special Enrollment Period, they may have to wait for the General Enrollment Period, which runs annually from January 1st to March 31st. Waiting until the General Enrollment Period can mean they may also face a late enrollment penalty that can continue for as long as they have Part B.

That potential delay is why it is better to determine eligibility and enrollment timing before turning 65 rather than trying to correct a missed deadline afterward.

A Simple Medicare Part B Checklist

Medicare enrollment is rarely a one-size-fits-all decision, particularly for people who continue working after 65. Taking time to verify how current insurance coordinates with Medicare can help prevent coverage gaps, unexpected bills, and late-enrollment penalties.

For healthcare professionals who spend their careers helping others, helping themselves by navigating their own Medicare transition with care can make all the difference when entering retirement.

Author’s Bio

Danielle K Roberts is the co-founder of Boomer Benefits who writes regularly for and is cited by many online publications. A TCU journalism graduate and former magazine editor, she enjoys sharing her Medicare knowledge online.

 

 

Please also review AIHCP’s Health Care Management Certification program and CE Courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Medical Waste Disposal Regulations: The Federal Baseline and Where Your State Takes Over

Posted on by Joseph Gerard

Medical waste disposal managementWritten by Forrest Webber,

The Agency Most Clinicians Name Is the One With the Least Authority

Ask a room of healthcare professionals who regulates medical waste and most will say the EPA.

The EPA has had almost no role in it for over thirty years.

Congress passed the Medical Waste Tracking Act in 1988 after syringes washed up on beaches in New York and New Jersey. It created a two-year federal demonstration program covering a handful of states, it ran from 1989 to 1991, and then it expired. The EPA studied the results, concluded that the disease risk from medical waste outside healthcare settings was low, and did not seek renewed authority.

What filled the gap was not a single federal replacement. It was fifty state programs, layered underneath two federal workplace and transport rules that apply everywhere.

That structure is why a practice administrator who moves from Tennessee to Alabama finds that the rules changed, and why a multi-site organization cannot write one medical waste policy and apply it across state lines. Understanding which layer governs which question is the difference between a compliance program that survives an inspection and one that only looks like it will.

The Federal Layer: Two Rules That Apply Everywhere

Three federal agencies touch medical waste, and only two of them govern the daily handling that clinical staff perform.

OSHA — the Bloodborne Pathogens Standard, 29 CFR 1910.1030. This is the rule most clinical staff are actually trained against, and it governs worker protection rather than disposal. It requires a written exposure control plan reviewed and updated annually, sharps containers that are closable, puncture-resistant, and leakproof on sides and bottom, containers labeled with the biohazard symbol or color-coded red, and training at initial assignment and at least annually thereafter.

Note what that standard regulates and what it does not. OSHA cares about protecting the employee from the waste. It has very little to say about where the waste goes after it leaves your building.

DOT — hazardous materials transport, 49 CFR. Regulated medical waste is a DOT hazardous material, shipped under UN3291 with packaging requirements at 49 CFR 173.197. Anyone who prepares those shipments for transport is a hazmat employee and needs training under 49 CFR 172.704, recurrent at least every three years.

That three-year cycle is the one most facilities miss, because it runs on a different clock than the annual OSHA training and nothing prompts it.

DEA — controlled substances. Separate regime entirely, under 21 CFR Part 1317. Controlled substances are not medical waste for disposal purposes and cannot be handled as though they were.

Everything else — what counts as regulated medical waste in the first place, how long you may store it, whether your transporter needs a permit, how long you keep the records — is a state question.

The State Layer: What Actually Varies

The federal rules are a floor. States build on top of them, and they build differently.

The definition itself varies. There is no single national definition of regulated medical waste. Some states enumerate categories. Others define it functionally. The practical consequence is that a waste stream classified as regulated in one state may be general solid waste a hundred miles away, and the staff sorting it have no way to know that from the federal rules alone.

Terminology varies. Florida regulates “biomedical waste”. New York regulates “regulated medical waste.” Other states say “infectious waste,” “special waste,” or “medical waste.” These are not interchangeable — searching your state’s code for the wrong phrase returns nothing, which is one reason facilities conclude their state has no rules when it does.

Which agency holds it varies. Most states place medical waste under their environmental agency. Florida places it under the Department of Health. A few split it between agencies depending on the waste type.

Transporter and treatment permitting varies. Some states require registration or permits for anyone hauling regulated medical waste. Some regulate on-site treatment technologies such as autoclaves separately and require validation testing on a set schedule.

Record retention varies. Tracking documents and treatment records commonly must be held for three years, but the period and the required contents differ by state — and that is separate from the six-year documentation retention HIPAA imposes on related records.

The Six-State Picture in the Southeast

A worked example of how much variation exists inside one region:

State Primary agency Term used
Alabama ADEM — Alabama Department of Environmental Management Medical waste
Tennessee TDEC — Department of Environment and Conservation Medical waste / special waste
Georgia Georgia EPD — Environmental Protection Division Biomedical waste
Mississippi MDEQ — Department of Environmental Quality Medical waste
North Carolina NC DEQ — Department of Environmental Quality Medical waste
Florida Florida Department of Health Biomedical waste

 

Six adjacent states, three different terms for the same material, and one of them does not even use its environmental agency. An organization operating across that footprint needs six policies, or one policy written to the strictest of the six.

In Alabama, the rules sit with the Alabama Department of Environmental Management. For facilities working through what those requirements mean in practice for a clinical setting, Alabama Medical Waste Disposal breaks them down.

What This Means for Your Compliance Program

Four things follow from the structure above, and they are the four places inspections tend to find problems.

Your written program has to name your state’s rule, not just the federal one. An exposure control plan that cites 29 CFR 1910.1030 and stops there is incomplete in every state that has its own medical waste rule. The plan should identify the state authority, the state’s definition of regulated waste, and the storage and recordkeeping limits that apply to your facility.

Segregation decisions belong to trained staff, not to whoever is closest to the bin. Over-segregation is the more common error and the more expensive one. Material that is not regulated medical waste — clean packaging, uncontaminated gloves, empty IV bags without free liquid in most states — costs several times more to dispose of as regulated waste than as solid waste. Under-segregation is less common but carries the actual risk.

Your training has to run on three separate clocks. OSHA bloodborne pathogens annually. DOT hazmat every three years for anyone signing shipping papers. Plus whatever your state requires, which in some states is neither. Facilities that run one annual training session and consider themselves covered are usually missing the DOT cycle.

The documentation is the compliance. In an inspection, a program you followed but did not document is indistinguishable from one you did not follow. Tracking documents, treatment records, training records with dates and content, and the annual review of your exposure control plan are what demonstrate the program exists.

For practices that would rather not build and maintain all of that internally, providers such as TriHaz Solutions deliver it as a managed program — OSHA, HIPAA and bloodborne pathogens requirements with the documentation and completion records attached, which is the part most facilities are missing when an inspector asks.

Sharps: The One Stream With the Least Variation

Sharps are the exception to most of the above. Every state regulates them, the federal container requirements are explicit, and the rules are more consistent across jurisdictions than any other medical waste stream.

The OSHA container standard is specific. Closable. Puncture-resistant. Leakproof on sides and bottom. Labeled with the biohazard symbol or color-coded red. Maintained upright, replaced routinely, and not allowed to overfill. Containers must be located as close as practical to the area of use, which is why a single container at a nursing station fails for a practice with multiple exam rooms. The FDA publishes guidance on sharps containers in health care facilities that is worth comparing against what your practice is actually using.

Where sharps get complicated is at the edges of the clinical setting — home health visits, patients self-injecting between appointments, satellite locations too small to justify a scheduled pickup, and the growing population of patients on GLP-1 medications who are injecting weekly at home and asking their providers what to do with the pens.

That last group is now a routine question in primary care, and the honest answer is that household trash is not acceptable in most jurisdictions. Mail-back programs from suppliers like Sharps Disposal Containers solve the low-volume cases — a container that ships back prepaid with documented destruction — and for practices they cover the satellite sites and home-health caseloads that do not generate enough volume for a route stop.

Where to Find Your State’s Rule

The fastest route is usually the state environmental agency’s solid waste division, searching for the term your state actually uses rather than the one you are used to. Try “biomedical,” “infectious,” “special waste,” and “regulated medical waste” before concluding nothing exists.

Your state hospital association and state medical or dental association often publish plain-language summaries that are more usable than the code itself, though they are summaries and the code governs.

Your waste vendor should be able to tell you your state’s storage limits and recordkeeping requirements without hesitating. A vendor who cannot is worth questioning, because those limits determine your pickup schedule.

Frequently Asked Questions

Does the EPA regulate medical waste?

Not in any meaningful way for most facilities. The Medical Waste Tracking Act expired in 1991 and was not renewed. The EPA retains authority over incinerator air emissions under the Clean Air Act and over hazardous and certain pharmaceutical wastes under RCRA, but routine regulated medical waste is governed by state programs, with OSHA and DOT layered on top.

Who regulates medical waste disposal?

State environmental or health agencies define and regulate it. OSHA regulates worker protection around it under 29 CFR 1910.1030. DOT regulates its transport under 49 CFR. The DEA regulates controlled substance disposal separately.

What are the federal requirements for medical waste disposal?

There is no federal disposal standard. The federal requirements that do apply are OSHA’s bloodborne pathogens standard, covering containers, labeling and training, and DOT’s packaging and hazmat training rules for shipment.

How often is medical waste training required?

OSHA bloodborne pathogens training is required at initial assignment and at least annually. DOT hazmat training is required at least every three years for anyone who prepares shipments. Some states add their own requirements.

What does regulated medical waste mean?

It depends on your state, because there is no single federal definition. Most states include cultures and stocks, pathological waste, human blood and blood products, contaminated sharps, and certain animal waste — but the specifics, and the thresholds, vary.

How long can medical waste be stored on site?

That is a state question, and the limits differ. Many states set a period measured in days at ambient temperature with a longer period under refrigeration. Check your state rule rather than assuming a national standard.

Is medical waste a DOT hazardous material?

Yes. Regulated medical waste ships under UN3291 with packaging requirements at 49 CFR 173.197, and staff who prepare those shipments are hazmat employees requiring training under 49 CFR 172.704.

Author’s Bio

Forrest Webber, analyst at TriHaz Solutions for 3 years, the leading medical waste disposal company in the Southeast.

 

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Clinical Work vs. Clerical Work: How to Get Back Hours Lost to Reports

Posted on by Joseph Gerard

Young stressed secretary in the office overwhelmed by work and desk full of files, her boss is bringing more paperwork to herWritten by Sawera Kousar,

Most psychologists did not spend years in training to format score tables on a Sunday night. Yet that is where many assessment hours end up. Testing sessions, interviews, and diagnostic reasoning make up the clinical side of an evaluation. Everything else, from copying numbers into a template to rewriting the same background paragraph for the tenth time, is clerical. This article shows where those hidden hours go and how to win a good share of them back without lowering your standards.

Where Report Hours Quietly Disappear

Report writing rarely eats time in one large block. It leaks away through small tasks that seem too minor to question:

  • Entering scores from publisher reports into a template
  • Reading intake forms and school records to pull out key facts
  • Rewriting standard sections such as referral reason and history
  • Fixing table layouts and fonts before export
  • Rechecking numbers for transcription errors

Each item takes only minutes. Together, they can add up to hours per evaluation, and none of them calls for clinical judgment.

Sorting Clinical Tasks From Clerical Ones

A simple test helps. If a task needs your training, judgment, or ethical responsibility, it is clinical. If it only moves information from one place to another, it is clerical.

Task Type Best handled by
Interpreting score patterns Clinical Psychologist
Reaching a diagnosis Clinical Psychologist
Writing recommendations Clinical Psychologist
Transferring scores into tables Clerical Automation or staff
Summarizing long records Mostly clerical Automated draft, clinician verifies
Formatting and exporting Clerical Automation

Once the clerical rows are visible, you can decide what to hand off. Some practices delegate that work to a psychometrist, while others use report writing software that turns uploaded scores and notes into a structured first draft for the clinician to review. Either route works, provided the psychologist keeps ownership of every conclusion.

Habits That Give Hours Back This Week

You do not need new technology to start. These five changes work in any practice:

  1. Build templates by referral type, such as ADHD, autism, or psychoeducational, so no report starts from a blank page.
  2. Write impressions and recommendations while the session is still fresh.
  3. Batch similar work: score entry in one block, editing in another.
  4. Keep a bank of reviewed phrasing for common findings, then adjust it for each client.
  5. Protect a fixed writing slot on your calendar, treated like a client appointment.

Pick one change and add another each week. Small adjustments are easier to keep than a complete overhaul, and each one returns minutes that add up across a full caseload.

What Automation Can Handle and What It Should Not

Automation fits repetitive work well: extracting scores, sorting records, drafting standard sections, and flagging missing or inconsistent data. Those tasks follow patterns, so a draft can arrive quickly.

A fast draft is only useful when the clinician still makes the call.

Interpretation, diagnosis, and sign-off stay with the psychologist. AI-generated text can contain errors or overstate a finding, so every line deserves a review against the raw data. Privacy matters just as much. Look for a signed Business Associate Agreement, clear data retention terms, and confirmation that patient data is not used to train models.

Questions to Ask Before You Pick a Tool

  • Does it support the tests and instruments you actually use?
  • Can you control template structure, prompts, and wording?
  • Does it flag inconsistencies before you sign?
  • Can you export to Word or PDF without reformatting?
  • Is there a trial so you can test it on a real case?

Common mistake: judging a tool by a polished demo alone. Test it with a messy, real case, including handwritten notes and incomplete forms, because that is what daily practice looks like.

Reclaiming Your Evenings One Report at a Time

Start small. Track one evaluation from intake to signature and mark every minute spent on clerical work. The biggest leak is usually easy to spot, and fixing that one step is a sensible place to begin. Clinical skill is the scarce resource in an assessment practice, so protect the hours that depend on it. Everything else can be streamlined step by step.

Quick Answers for Busy Clinicians

How many hours can I realistically save per report?
 It depends on your caseload, assessment type, and how much of the process is already templated. Track your hours across a few reports before changing anything, then compare the numbers afterward. Measured results are more reliable than any general estimate, including the ones vendors advertise.

Is it ethical to use AI when writing psychological reports?
 It can be, as long as the clinician reviews, edits, and signs every report, and patient data stays protected under proper agreements. Rules differ by region and licensing board, so check current guidance from your own board and professional association before adopting any tool.

How does Psynth protect patient data?
 According to the company, Psynth is HIPAA-compliant and signs a Business Associate Agreement with practices on every plan. Its AI vendors do not retain data, patient data is not used to train models, and clinicians can request deletion of stored reports and uploads at any time. Review its Trust Center for current certifications.

Will automated drafts sound like me?
 Only if you shape them. Set your section structure, prompts, and preferred wording in a template, then edit each draft the way you would edit a trainee’s work. Your voice comes from the review pass, not from the first draft.

Author’s Bio

Sawera Kousar is a content writer who focuses on health, wellness, and medical topics. She aims to provide clear, informative, and reader-friendly content to help readers better understand important health-related subjects.

 

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Why Young Adulthood Can Be a Critical Time for Mental Health Support

Posted on by Joseph Gerard

healthy young man practice yoga in height mountain at early morning and sunrise

Written by Esme Wang,

Young adulthood is often associated with independence, opportunity, and new experiences, but it can also bring significant emotional and practical pressures. Young people who are struggling with mental health concerns, substance use, or both can learn about addiction treatment for young adults and the structured programs designed specifically to address these challenges during this stage of life. Understanding why young adulthood can be a particularly vulnerable period helps families, professionals, and young people recognize when additional support may be beneficial.

Major Life Changes Can Create Emotional Pressure

Young adults’ lives are marked by a series of significant changes that can happen in a short period. When you move out, start college, enter the job market, manage finances, and start serious relationships, new responsibilities can arise. Positive change can bring stress, even when it’s good.

These pressures can be greater when several changes happen at once. A young adult is trying to get good grades and/or a good job, form relationships, learn to manage money, and make plans for life. If we don’t know how to deal with the stress, emotional problems may slowly start interfering with our daily lives.

Mental Health Challenges May Become More Noticeable

A few mental health issues can arise during adolescence and young adulthood. Abnormal changes in affect/motivation/sleep/attention/social interactions should be considered first as a normal stress response. Changes to education, work, relationships and/or daily living activities may indicate additional support is required if these changes persist.

As youth age, it can be difficult to discern the problems in holding them back or to know when to push them to become independent. They might not want to discuss what they’re experiencing because they don’t want to upset people in the family, or not be able to be an adult when they grow up. When there are open discussions, issues may be identified early, before they cause greater problems.

Substance Use Can Complicate Mental Health

Youth may also encounter alcohol and drugs in new situations during their young adult years. Some people may use drugs for fun, while others may begin using drugs to manage stress, anxiety, difficult emotions, or situations. When it is used as a coping mechanism, it may cause additional distress or issues.

Substance use and mental health problems may co-occur. This can make it difficult to determine which problem occurred first and which symptoms are associated with a particular problem. When supporting, the following should be taken into account: the relationship between these two aspects is not considered independent of each other.

Early Support Can Prevent Problems From Escalating

It’s never too late for a young person to seek help. Early help may facilitate understanding of what is causing emotional distress and help individuals develop a healthier way to manage it. Earlier interventions also may avoid concerns having a negative impact on education, work, relationships and other life areas.

The type of support a person may receive will vary according to his/her circumstances and the degree of challenge. A small number of young adults might need continuing counseling, and some young adults might need more intense mental health or drug treatment. Treatment needs to be tailored to individual needs and not just a one-size-fits-all.

Healthy Coping Skills Support Growing Independence

Adolescents and young adults are at the age to begin their adulthood responsibilities, which they once shared with parents, teachers, and others. These duties can be easier to handle if you’ve learned to manage stress, regulate your emotions, solve problems, and communicate effectively. These skills can also be used to help you resolve issues in the future.

Healthy habits can help with emotional wellness, too. Young adults can deal more effectively with daily stress by establishing a reasonable objective, exercising, enjoying healthy relationships, and getting adequate sleep. With the help of professionals, individuals can identify the coping strategies they are going to use and understand which habits are best suited for them.

Families Can Remain an Important Source of Support

Independence isn’t the end of the need for family support. Emotional support, help, and stability from parents and other family members can be helpful when a young person is assuming new responsibilities. The challenge is to support whilst encouraging increased independence.

Families can assist and be mindful of any positive behavior changes and not assume why. Families can communicate more safely by listening, being concerned, and providing professional support as needed. The family members also do not have to be responsible for all of the young adult’s decisions, so healthy boundaries must also be established.

Treatment Should Reflect the Individual

Youth are not all having the same experience of transitioning to adulthood. They might require different services depending on their mental health and substance use, relationships, education, employment, family situation, and history. Treatment can thus be more beneficial if it takes into account the whole person rather than just one symptom or problem.

One-on-one supports can also help youth set goals that are relevant to their lives. For one person, it can be a return to school; for another, it might be a new job, a new relationship, or a better habit. It may be a return to school, keeping a job, mending a relationship, or creating new habits for one person. It can be a return to school, a job, mending a relationship, or new habits for one person. Linking treatment to real-life goals can help to make recovery real-life.

Building a Stronger Foundation for Adulthood

Adolescent experiences and habits impact their adult life. Awareness of emotional challenges, seeking help, establishing healthy boundaries, and healthy stress management can be used to help develop skills for years. Mental health support can not only help to manage immediate struggles, but can also build resilience.

Being young doesn’t have to be a difficult time; it can be productive and meaningful. Learning to be self-sufficient may have some challenges, uncertainties, and failures in it, but if there are continued mental health and/or substance use problems, these should be addressed. Timely support can be helpful for young adults to understand what is happening and continue to build their skills and confidence for the future.

Conclusion

Many mental health and substance use issues can be harder when transitioning to adulthood, when there is opportunity for growth and challenges. Major life changes, increasing independence, shifting relationships, and new responsibilities can affect emotional wellbeing, so it is important to recognize this and support young adults early. Young adults can build a foundation for the years ahead by being encouraged to communicate freely, use healthy coping strategies, and receive individual care and prompt professional help.

About the Author:

Esme Wang is a copywriter and content strategist. She helps businesses stop playing around with content marketing and start seeing the tangible ROI. She loves writing as much as she loves the cake.

 

 

 

Please also review AIHCP’s Substance Abuse Practitioner Program and  CE courses to see if it meets your academic and professional goals.

Sustainable Clinical Practice for Nurses, Social Workers, and Counselors

Posted on by Joseph Gerard

Diverse team of health care professionals

Written by Lucy Peters,

Environmental sustainability is no longer just a buzzword in health and social care settings. Reducing the carbon footprint of clinics, hospitals, and hospices has become a vital priority, as the healthcare sector accounts for around 5% of global greenhouse gas emissions. Medicines, equipment, packaging, and services used in everyday care account for a large share of healthcare’s carbon footprint. For nurses, social workers, and counselors, these issues can affect their patients and the environment in very real ways. Climate change measurably affects respiratory illness, heat-related harm, food insecurity, displacement, and mental health. Even providing patient care can contribute to the problem through energy use, waste, travel, and supply chains. However, many professionals are ready and willing to act, and they are well positioned to do so because their daily decisions affect energy and other resource use. By making small, consistent changes instead of aiming for perfection, they can protect their patients and protect the environment for generations to come.

 

Why Green Practices Matter in Clinical Settings

The environmental footprint of healthcare and community services can be significant, ranging from single-use plastics to water use. Research from Practice Greenhealth, a leading healthcare sustainability nonprofit, found that hospitals produce over five million tons of waste every year, or about 29 pounds per staffed bed per day. Research shows that operating rooms are epicenters of healthcare waste. These spaces generate up to 33% of a hospital’s total waste while accounting for up to 60% of its supply budget. A single procedure can fill several bags before a patient leaves the OR. The World Health Organization notes that about 85% of healthcare waste is classified as “ordinary,” or non-hazardous. This waste includes paper, packaging, food scraps, and plastics. Two additional sources of emissions are healthcare-related travel (including home visits, meetings, and training sessions) and water use. Statistics show, for instance, that most U.S. hospitals using an average of 570 gallons of water per staffed bed per day.

 

The Problem with Single-Use Plastic

A 2026 study by Nathalia Silva de Souza Lima Cano and colleagues quantified single-use plastic consumption across five U.S. healthcare facilities, finding annual amounts ranging from 20.2 tonnes at a surgical center to 711.5 tonnes at a large hospital with 1,400 beds. Two materials are of particular concern: polyisoprene, a synthetic rubber, and polypropylene (PP), which is used in rigid plastics and nonwoven fabrics. High-consumption products include personal protective equipment (PPE), sterilization wraps (or blue wrap), and fluid collection systems. The researchers concluded that redesigning product weight and items such as glove dispensers could reduce polymer use. Moreover, replacing fossil-based materials with bio-based alternatives in select applications could reduce the global warming potential of some materials by 16.3% without requiring changes to existing production lines.

 

Energy Use in Healthcare Settings

Energy is another major contributor to climate change. U.S. hospitals use an average of 738.5 kWh/m² annually, which is about 2.6 times more energy than typical commercial buildings. Hospitals represent roughly 4% of commercial floor space but consume about 9% of all U.S. commercial building energy, with heating, cooling, and ventilation accounting for 72% of that demand. To cut energy use and emissions, more healthcare centres are adopting renewable energy. Hospitals are incredibly energy-dense, and they run 24/7. Therefore, the shift to greener operations relies on all-electric facility designs, on-site solar microgrids, and green power purchase agreements (PPAs). Healthcare isn’t the only sector making this transition. A wide array of energy-intensive industries is lowering energy costs while significantly reducing their carbon footprints. The savviest of these businesses are meeting a large percentage of their energy needs and generating surplus energy they can export to the grid. Healthcare facilities can adopt a similar strategy, using renewables and microgrids to lower energy costs, reduce emissions, and supply energy back to the wider network. 

Key Responsibilities for Battling Climate Change

The studies and statistics above show that many of the most significant sources of waste require intervention from healthcare organizations and governments. Healthcare groups can adopt key strategies such as reducing reliance on single-use plastics, cutting water waste, and investing in solar and other renewable energy sources. Governments, meanwhile, can help by offering modernization grants to hospitals and clinics and mandating national renovation plans for poor-performing hospitals and clinics. They can also offer tax incentives, support restructuring healthcare delivery, and encourage green suppliers for everything from medical devices to pharmaceuticals.

 

Nurses, Social Workers, and Counselors Also Play a Decisive Role in a Greener Future

Nurses, social workers, and counselors can also do their share through their everyday choices and behaviors. For instance, they can maintain equipment properly to extend its lifespan and keep it running efficiently. Energy-saving habits, such as switching off lights, computers, printers, and chargers when not in use, can reduce unnecessary energy consumption. Equally important is reporting energy waste, faulty equipment, excessive heating or cooling, and opportunities to improve efficiency. Professionals can advocate for useful changes such as adopting energy-efficient lighting, using long-lasting equipment, and relying on renewable energy. They can raise sustainability issues at team meetings, support green champions in their organizations, and encourage their managers to seek funding for sustainability initiatives. They can also lead by example and encourage others (both colleagues and patients) to adopt sustainable behaviors. Transport is another important area for action. Professionals can use lower-emission commuting options, coordinate home visits across care teams to avoid multiple separate journeys to the same location, and choose lower-emission options for meetings and training. They can also advocate for greener transport policies.

 

Specific Actions to Take

Each professional can contribute to healthcare sustainability. For instance, nurses can avoid unnecessary disposable supplies, choose reusable alternatives when infection-control protocols allow, and ensure waste is correctly segregated. They can also help educate patients, encourage responsible medication use, and reduce unnecessary repeat procedures. Social workers, meanwhile, can connect vulnerable patients with local support services, help them access community-based care, and advocate for services that reduce unnecessary hospital admissions and reliance on resource-intensive settings. When appropriate, they can support telehealth consultations to reduce travel-related emissions while improving access for people with mobility difficulties or limited transportation options. Counselors can also offer remote sessions when appropriate, use digital resources instead of printed materials, recognize how environmental stressors affect psychological well-being, and advocate for green spaces and sustainable practices in their clinics. All three professions can involve staff in sustainability committees, contribute to environmental audits, and help identify practical changes that can improve energy use and reduce waste.

 

Hospitals and clinics have a significant carbon footprint that needs to be reduced. Governing bodies and state and federal governments bear most of the responsibility, since many measures (including renewable energy) must be implemented at the organizational level. However, nurses, social workers, and counselors can all contribute to sustainability goals in their daily lives. Advocacy, green practices, and a reduced transport footprint can significantly reduce waste and pollution.

 


Author bio

Lucy is a freelance writer who enjoys contributing to a range of publications, both in print and online. She spent almost a decade working in the care sector with vulnerable people before taking a step back to start a family and now focuses on her first love of writing.

 

Please also review AIHCP’s Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

4 Ways Healthcare Professionals Can Evaluate Clinical Research Quality 

Posted on by Joseph Gerard

Professional team of scientists is working on a vaccine in a modern scientific research laboratoryWritten by Deepika

If a disease is to be cured or prevented, clinical research is the first right step in that direction. That is what led to a 44% decline in the breast cancer mortality rate since 1989. The Alliance for Clinical Trials in Oncology highlighted the critical role clinical research plays on World Breast Cancer Research Day. 

Had patients not participated in clinical trials over the past decades, many advancements in medical science would still be a part of someone’s imagination. However, success depends on the quality of the clinical research: its methods, data, and reporting standards. 

In April 2026, the US Food and Drug Administration (FDA) reported that 29.6% of studies that were likely to face mandatory reporting requirements had no findings submitted to ClinicalTrials.gov. 

Healthcare professionals can analyze research quality by examining how studies are designed, conducted, and applied to patient care. Here are four ways to assess the strength and practical relevance of clinical evidence. 

Put the Study Design and Risk of Bias to the Test 

A study’s conclusions can only be as reliable as the methods used to reach them. A good place to start is to assess whether the research design suits the question being investigated. Also, check if the comparison groups are appropriate and if the follow-up period supports the conclusions. 

Randomized controlled trials can help evaluate the effects of interventions. On the other hand, observational studies are useful for examining associations and risk factors. Without sound execution, neither of the two guarantees findings that can be trusted. A 2026 study showcases the importance of methodological details. 

By means of Monte Carlo simulations of randomized controlled trials with 48, 240, and 1,200 participants, researchers discovered something of value. Conventional permuted block randomization could make treatment assignments more predictable. Overall, researchers found that the method used to assign participants can influence selection-bias risk, even when the trial is described as randomized. 

What to Look For 

The takeaway here is not to confine the study to a box of headline conclusions to identify potential sources of bias. In the case of randomized trials, check whether the allocation sequence was truly random and hidden from the participants. 

If it is an observational study, consider whether researchers accounted for confounding factors such as age, disease severity, and concurrent treatments. Regardless of the study type, it’s important to examine missing data, participant withdrawals, and the relevance of statistical methods for the research question. 

You do not have to reject research whenever limitations exist. However, the aim is to determine whether those limitations can affect the results and in what ways. 

Review Ethical Standards and Clinical Compliance 

Clinical compliance is what ensures that trials protect participants and follow approved procedures. Good Clinical Practice (GCP) establishes standards for responsible trial conduct, including informed consent and participant safety. 

If these standards are not followed, the consequences can extend beyond procedural failures to affect public trust in clinical evidence. A 2025 report by the FDA shows why accountability matters. During that fiscal year, the agency issued 42 Preliminary Notices of Noncompliance to parties that failed to meet applicable ClinicalTrials.gov registration or results-reporting requirements. 

Nearly 90% posted the required information later. Although related to reporting compliance, these figures show how regulatory oversight can help address cracks in the public record. The same goes for ethical standards. Participants should understand a study’s purpose, potential risks, and possible benefits before they give their consent. 

Independent ethics review and appropriate safety monitoring help protect their rights throughout the research process. However, regulatory approval or documented compliance alone is not enough; critical evaluation is still needed. 

What to Look For 

First, see if the ethics committee or institutional review board shares how informed consent was obtained. Look for evidence of complete protection of participants’ rights and privacy throughout the trial. Also, as Just in Time GCP notes, comparing trial documentation with the approved study plan can help expose inconsistencies that may require further checks. 

Moreover, the published report must be compared with the trial registration and available protocol to see if the study’s conduct and reported outcomes are consistent. Ultimately, compliance provides an essential foundation for ethical research. At the same time, careful evaluation of study design determines clinician confidence in the findings. 

Scrutinize Data Integrity and the Transparency of Results 

When we speak of clinical evidence that can be trusted, it’s not just about the research design. Healthcare professionals also need to assess how researchers recorded, analyzed, and reported the insights. Incomplete methods or missing results can make it difficult to reproduce a study or determine if its conclusions can be justified. 

A recent systematic review tested 461 records relating to clinical trials of large language model (LLM) interventions in medicine. This included 68 trial reports, 15 protocols, and 378 registrations. Among the full trial reports, the average reporting score was just 44% under the CONSORT 2025 guideline for randomized trials. 

The same was 59% under its AI-specific extension, CONSORT-AI. The results here suggest that crucial methodological details may be missing even when studies communicate their main objectives and conclusions. Be it AI-related clinical trials or not, readers require adequate information to verify how reported results were obtained. 

What to Look For 

First, compare the published study with its trial registration, protocol, and available statistical analysis plan. See if the reported primary outcomes match those originally specified and if the changes are explained. 

While differences do not serve as evidence of misconduct, unexplained changes warrant closer scrutiny. Also, look for trial registration details, supplementary materials, and data availability statements that enable scrutiny. What you’re trying to decipher is whether the presented evidence allows readers to understand how researchers reached their conclusions. This will reveal any remaining uncertainties too (if applicable). 

See if the Findings Apply to Real-World Patients 

Despite being sound from a methodological viewpoint, a study’s results may not apply equally to every patient population. This is what is known as external validity: the test of whether findings of a study will hold for the people and healthcare settings in which the treatment will be used. 

Participant representation is an important part of this assessment. A 2026 analysis of 58,163 clinical studies registered on ClinicalTrials.gov found that 44.8% did not report participants’ race or ethnicity. Although reporting improved over time, the gaps make it difficult to understand whose experiences are reflected in the evidence. 

Thankfully, efforts to improve representation are gaining momentum, especially in the pharmaceutical industry. According to a recent Reuters report, Jim Swanson, the Executive Vice President and Chief Information Officer at Johnson & Johnson, explained the rationale for recruiting diverse trial populations. He said, “We treat patients all around the world, and so we want to make sure that in our clinical studies they represent the patient populations that we’re serving.” 

He further added that AI was being used to accelerate enrollment with diverse patient populations. Besides representation, let’s remember that age, disease severity, medication use, and the research setting also affect how results translate into routine care. 

What to Look For 

Healthcare professionals must compare study participants with the patients who need to be treated. Consider age, demographic representation, comorbidities, and medication use. Go through the exclusion criteria carefully, since they may leave important patient groups underrepresented. 

At the same time, it’s vital to check whether the authors acknowledge limitations in applying their findings to other populations. You’re trying to understand not only whether a treatment worked, but also under what circumstances and how its benefits extend beyond the study. 

FAQs 

How can healthcare professionals identify bias in a clinical study? 

Healthcare professionals should assess if the research design suits the question and confounding factors are addressed. They should also examine randomization, missing data, and statistical methods to determine whether limitations could influence findings. 

What’s the importance of ethical standards and transparent reporting in clinical trials? 

Ethical standards are meant to protect participants in a trial through informed consent and safety monitoring. Transparent reporting allows readers to know how researchers conducted the study and addressed unexpected outcomes. This makes it easier to assess the credibility of the results shared. 

How can clinicians determine whether research findings apply to their patients? 

Clinicians should compare study participants with their own patient populations. So, they must consider age, medication use, and demographic representation. They should also analyze differences between trial conditions and routine care to see if independent researchers can verify the results. 

 

Clinical Research Quality: Key Checks At a Glance 

Area to Evaluate  What to Check 
Study design  Appropriate methodology, comparison groups, and follow-up duration 
Risk of bias  Randomization, confounding factors, and participant withdrawals 
Ethical conduct  Informed consent, ethics approval, and safety monitoring 
Data transparency  Trial registration, outcome consistency, and accessible documentation 
Patient relevance  Participant diversity, exclusion criteria, and real-world application 
Ability to reproduce data  Whether independent researchers can verify the results 

Clinical research is to be treated as a foundation for clinical judgment, not a substitute for it. One useful final test is whether independent researchers can verify the conclusions using the underlying data and analytical methods. 

For a March 2026 study, five teams independently reanalyzed data from a randomized trial of rectal cancer treatment. The teams largely reproduced the key disease-free survival findings. However, they also encountered missing documentation and a broken link to the original protocol. 

Such obstacles show that even credible results can be difficult to scrutinize if research materials are inaccessible. Your high-quality clinical research ought to not only support a promising conclusion, but also make the conclusion open to examination. This is the gold standard that ensures clinical decisions are based on findings that can be tested, questioned, and trusted. 

References 

  1. Alliance highlights the importance of clinical research on World Breast Cancer Research Day. August 2026. News Medical. 

https://www.news-medical.net/news/20260818/Alliance-highlights-the-importance-of-clinical-research-on-World-Breast-Cancer-Research-Day.aspx

  1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. April 2026. FDA News Release. 

https://www.fda.gov/news-events/press-announcements/fda-reminds-more-2200-sponsors-and-researchers-disclose-trial-results

  1. Office of Compliance 2025 Annual Report. April 2026. US Food & Drug Administration Center for Drug Evaluation and Research. 

https://www.fda.gov/media/192091/download

  1. Chen David. Blayne Ayden, et al. Reporting completeness of clinical trials evaluating large language model interventions in medicine: systematic review. October 2026. BMJ. 

https://www.bmj.com/content/395/bmj-2026-100855

  1. Erman Michael. J&J sees AI halving the time to generate drug development leads. April 2026. Reuters. 

https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sees-ai-halving-time-generate-drug-development-leads-2026-04-27/

  1. Burgwinkel Cora, Chaim Chang Han, et al. Supporting reanalysis and reuse of clinical trial data: a case study. March 2026. Springer Nature Link. Volume 27, article number 351. 

https://link.springer.com/article/10.1186/s13063-026-09646-y

Author Bio

Deepika has over six years of experience as a writer and editor. Passionate about words and learning, she takes an interest in a variety of niches. Her knack for turning complex ideas into relatable narratives allows her to resonate with the reader. When her pen falls silent, you can find her engrossed in a novel or getting her hands messy with fine arts. Through these, Deepika is committed to keeping her curiosity and creativity alive. 

 

 

 

Please also review AIHCP’s Health Care Ethics Certification and Clinical Research Specialist Certification programs see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

What nurse managers should check before a new infusion set reaches the unit

Posted on by Joseph Gerard

Hospital Ward: Professional Black Head Nurse Wearing Face Mask Does Checkup of Patients Vitals, Checking Heart Rate Computer, Intravenous or Iv Fluids Drip Bag.Written by Laura Bennett,

A switch to a new IV set can change how secondary infusions behave on the unit. What nurse managers can ask suppliers, cover in staff training and look for after an incident.
The change usually arrives with little notice. A supply contract is renewed, a product is back-ordered, and one morning the IV sets in the clean utility room come from a different manufacturer. They look almost the same.

A week later an incident report lands on the nurse manager’s desk: an antibiotic hung as a secondary infusion ran long, and part of it seems to have gone into the primary bag. Nobody did anything obviously wrong, which is exactly why a change of infusion set deserves the same attention as a change of practice.

Why a small valve becomes a management question

Most primary IV sets used for piggyback infusions contain a back-check valve above the port where the secondary line joins, and in a typical setup it is the height difference between the two bags that makes it work. When the secondary bag hangs higher than the primary, its greater pressure closes the valve and the pump draws from the secondary alone.

If the valve fails to seal, the pump keeps pulling primary fluid alongside the drug, or part of the dose flows back into the primary bag, and the patient receives less than was ordered or gets the rest later than intended.

Bench testing and device literature usually trace those failures to too little height between the two bags, high secondary flow rates or air trapped in the valve. All three depend on how sets are hung and primed, so the risk sits partly with the device and partly with the routine around it, and a manager is the person who oversees both.

Units that handle blood, such as dialysis, apheresis or areas where samples are drawn through closed systems, carry one more concern. Blood that sits in a recess of a connector or valve tends to clot, and red cells forced through tight, turbulent passages can break down, so the less dead space a valve has, the better it suits a blood line.

Valves that route flow around a disc or a ball can leave pockets behind the sealing element, which is why blood-contact applications often rely on duckbill valves, whose two elastomer lips part in the direction of flow and keep the path nearly straight. Some manufacturers design them specifically for this use. Vernay, a fluid control manufacturer founded in 1946 and based in Georgia, for instance, makes SupraValve® duckbill check valves for blood handling, dialysis and IV lines, with an interior built to remove dead space and keep priming volume low.

Evaluating the set with the people who will use it

Many hospitals route new products through a value analysis committee, where supply chain staff, physicians and nurses, often joined by clinical engineering, compare options before a contract is signed. A nurse on that committee can ask questions that a price comparison will miss.

Which way must the valve face, and how is that marked? What reverse pressure was it tested against? Can staff see air in the line through the housing? And for blood lines, how does the design deal with dead space? Nobody on the committee needs to judge the engineering, only to make sure the supplier answers these questions in writing before the product is approved.

Connectors belong on the same list. The FDA has received reports of deaths and serious injuries from tubing misconnections, and enteral feeding delivered into IV lines is among the best-documented examples.

The ISO 80369 series gives each type of line its own connector so that one cannot be joined to another. Sets for IV use should carry connectors that meet ISO 80369-7, the part that covers intravascular Luer fittings.

Training before the first bag is hung

A new set changes small habits, and small habits are where secondary infusions go wrong. A short in-service before the switch, held at the pump rather than in a classroom, can cover the points that matter most.

Staff should hang the secondary at the height the set instructions call for, clear air from the valve during priming and watch the primary drip chamber once the secondary starts, since a primary that keeps dripping means the valve is not holding. A laminated card on the pump pole with the same three steps costs almost nothing.

Competency checks work better when they are observed rather than signed off. Asking each nurse to set up one secondary infusion with the new tubing, while a charge nurse or educator watches, shows quickly who has understood and where the instructions for use are unclear.

Night and weekend staff, agency nurses and float pool nurses are easy to miss in a rollout and may meet the new set before anyone has shown them how it works.

After an incident, look at the set as well as the nurse

When a secondary dose runs late or short, the first question is often who hung it. A review that stops there will miss a device problem that can repeat on any shift.

Setting the tubing aside unaltered, noting the lot number and recording bag heights and pump rates turn a single report into evidence, and clinical engineering or risk management can then arrange an analysis with the manufacturer.

Hospitals must report device-related deaths to the FDA and the manufacturer, and serious injuries to the manufacturer, while malfunctions that caused no harm can still be reported voluntarily through the FDA’s MedWatch program.

Manufacturers have issued recalls and correction notices for sets with faulty back-check valves, and a unit that has documented its own cases is in a better position to recognize one. Sharing the outcome with staff, including what was found about the equipment, also tells nurses that reporting a near miss leads somewhere.

Frequently Asked Questions (FAQ)

What does a value analysis committee do in a hospital?

A value analysis committee reviews new medical products before they are purchased, weighing clinical evidence, safety, cost and usability. It usually brings together supply chain staff, physicians and nurses, often with clinical engineering, so that the people who will use a device have a say in choosing it.

How should a secondary IV infusion be set up to prevent backflow into the primary bag?

The secondary bag is usually hung higher than the primary, as the set and pump instructions specify, so that the back-check valve in the primary line closes. Air should be cleared from the valve during priming, and once the secondary starts, the primary drip chamber should stop dripping.

Who should report a malfunctioning IV set in a US hospital?

Any clinician can report a device problem voluntarily to the FDA through MedWatch, and the FDA also asks clinicians to follow their facility’s internal process, usually run by risk management. The facility itself must report device-related deaths to the FDA and the manufacturer, and serious injuries to the manufacturer.

Author Bio

Laura Bennett is a freelance writer who covers hospital operations and medical technology. Her work looks at the practical side of patient safety, from how equipment is chosen and introduced on the ward to what frontline teams need to know before they use it.

 

Please also review AIHCP’s Nursing Management Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification